Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07180979 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 7, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2026 to Sep 15, 2025
    v3
  2. Start date: Oct 1, 2025 to Mar 1, 2026
    • Interventions: 0.9% Sodium chloride (Drug), Ropivacaine 0.2% Injectable Solution (Drug), Ropivacaine 0.2% Injectable Solution (Drug) to Ropivacaine 0.2% Injectable Solution (Drug), Ropivacaine 0.2% Injectable Solution (Drug), Ropivacaine 0.5% Injectable Solution (Drug)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate whether different types of regional anesthesia can improve pain control and functional recovery after total hip arthroplasty in adult patients undergoing elective hip replacement surgery. The main questions it aims to answer are: Does the PENG block reduce opioid use in the first 48 hours after surgery more effectively than the combined L-ESPB + S-ESPB technique? Which method provides better pain relief, preserves muscle strength, and supports earlier mobilization? Researchers will compare the Pericapsular Nerve Group (PENG) block with the combination of Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB + S-ESPB) to see which provides better pain control, fewer side effects, and faster recovery. Participants will: Be randomly assigned to receive one of the two types of ultrasound-guided regional anesthesia Undergo standard hip replacement surgery under spinal anesthesia Be monitored for pain scores, opioid use, time to first walking, muscle strength, satisfaction, and side effects over the first 48 hours after surgery.
Trial Details
NCT Number NCT07180979
Lead Sponsor Poznan University of Medical Sciences
Conditions
(from sponsor)		 Hip Osteoarthritis, Hip Arthropathy, Hip Pain Chronic
Related terms Osteoarthritis, Hip
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov